Page last updated: 2024-12-07

5-aminoindole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-Aminoindole is a heterocyclic compound with potential biological activity. It is an indole derivative with an amino group at the 5-position. 5-Aminoindole has been studied for its potential as a precursor to various biologically active compounds, including pharmaceuticals and agrochemicals. Its synthesis typically involves the reaction of indole with an appropriate amine source, followed by deprotection or other modifications. Research has explored its role in various biological processes, including its interaction with enzymes, its effects on cell signaling, and its potential as an anticancer agent. The compound is also studied for its photophysical properties and its potential in materials science applications.'

5-aminoindole: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1H-indol-5-amine : An indolamine carrying an amino group at position 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID78867
CHEMBL ID325916
CHEBI ID33067
SCHEMBL ID130519
MeSH IDM0500331

Synonyms (52)

Synonym
AC-5465
BIDD:GT0124
EN300-28737
unii-q732pg0y16
einecs 225-977-2
q732pg0y16 ,
nsc 61452
SDCCGMLS-0066200.P001
1h-indol-5-amine
5192-03-0
nsc-61452
nsc61452
indole, 5-amino-
5-aminoindole
indol-5-ylamine
CHEBI:33067 ,
5-aminoindole, 97%
A-5640
inchi=1/c8h8n2/c9-7-1-2-8-6(5-7)3-4-10-8/h1-5,10h,9h2
zcbifhndzbscep-uhfffaoysa-
AKOS000280236
CHEMBL325916
A22084
5-indolamine
A-5645 ,
STK711129
FT-0601203
PS-4506
AM1048
AB00443549-03
SCHEMBL130519
5 -aminoindole
1h-indol-5-ylamine
5-indole amine
5-amino-indole
1h-indole-5-amine
(1h-indole-5-yl)-amine
5amino-1h-indole
5-amino-1h-indole
1h-5-indolylamine
5-amino indole
DTXSID5063734
cid_78867
bdbm32210
CS-W007509
mfcd00005679
NCGC00342252-01
SY014519
Q27115500
SB14953
(indol-5-yl)amine
Z271138340
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
indolamine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
90-kda heat shock protein beta HSP90 beta, partialHomo sapiens (human)IC50 (µMol)50.00000.17369.803229.2701AID712
heat shock protein HSP 90-alpha isoform 2Homo sapiens (human)IC50 (µMol)50.00000.17369.803229.2701AID712
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID54188Residual Cyclin-dependent kinase 5-p35nck5a activity with L240C/N297Q mutant cytochrome P450 2A6 extract2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.
AID73213Residual porcine GSK-3-alpha/beta kinase activity with L240C/N297Q mutant cytochrome P450 2A6 extract2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis.
AID1890260Antitubercular activity against Mycobacterium smegmatis ATCC 700084 after 48 hrs by microdilution assay2022Bioorganic & medicinal chemistry letters, 05-01, Volume: 63Structure-activity relationship of 2-aminodibenzothiophene pharmacophore and the discovery of aminobenzothiophenes as potent inhibitors of Mycobacterium smegmatis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (20.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's4 (40.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.69

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.69 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.51 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.69)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]